Adagene Reports Financial Results for the Six Months Ended :

– Topline data for anti-CTLA-4 antibody, ADG116, shows compelling clinical safety and complete and partial responses as both a single agent and in...

Related Keywords

Australia , Japan , Sanjin , Japan General , United States , Paris , France General , France , Singapore , Suzhou , Jiangsu , China , Boston , Massachusetts , American , Powerbody Tces , Peter Luo , Adagene Inc , Holding Foreign Companies Accountable Act , American Society Of Clinical Oncology , Linkedin , Human Research Ethics Committee , Twitter , Nasdaq , Exchange Commission , Development Rd Expenses , American Association For Cancer Research , European Union , Dynamic Precision Library , European Society For Medical Oncology , Chief Executive Officer , Annual Meeting , Clinical Oncology , European Society , Medical Oncology , Cancer Research , Dragon Boat Biopharmaceutical , Greater China , Cash Equivalents , Shares Outstanding , Media Contact , Nasdaq Adag , Dagene Inc ,